Here's Why You Should Retain Charles River (CRL) Stock Now
Published on: Wednesday 17 May 2023
Charles River Laboratories International, Inc. CRL is well-poised for growth in the coming quarters, backed by strategic acquisitions and the robust performance of the Discovery and Safety Assessment (“DSA”) segment. The company’s recently released 2023 first-quarter results instill investors’ optimism. However, the nonhuman primate (NHP) supply situation and foreign exchange headwinds do not bode well for the Charles River. In the past year,...
RELATED NEWS
